Excel Industries Q1 FY27: Revenue Rs 293.73 cr, PAT Rs 29.11 cr, both down YoY

Revenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

EXCELINDUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹1045.00

prior close

₹1035.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-2.0% vs market

Specialty Chemicals peers, median of 94sector-0.1%-1.8% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.8

10m

-2.7

15m

-3.8

30m

-4.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9+0.1-2.0-0.1-1.8

Next day

-6.4+0.2-6.6-1.1-5.3

-6.1+0.6-6.7-0.8-5.2

+8.0-0.0+8.1-1.2+9.2

+6.7+0.5+6.2-1.3+8.0

+3.8+0.8+3.1-1.0+4.8

+1.3+0.6+0.7-1.0+2.4

15d

-1.5+1.3-2.8+0.9-2.4

-7.6-1.4-6.2-1.9-5.7

-12.3-0.6-11.7-0.5-11.7

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 standalone revenue from operations fell to Rs 293.73 cr from Rs 309.47 cr YoY, a decline of around 5 percent. Profit after tax dropped to Rs 29.11 cr from Rs 33.56 cr, down about 13 percent YoY. Sequentially against Q4 FY26, revenue rose 4.5 percent and PAT more than doubled. EBITDA margin compressed slightly to about 16.2 percent from 16.8 percent YoY. Limited review report by Price Waterhouse was unmodified with no qualifications. Company operates in a single Chemicals segment.

Likely market impact

Revenue and profit both declined YoY though sequential numbers improved from a soft Q4. Mild margin pressure visible. No red flags from auditor.